See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Odile Rundquist, Phd profile image

Odile Rundquist, Phd

Jury member Biotech at Venture Kick
Intro Book
Odile Rundquist, a seasoned expert in pharmaceutical industry, biotechnology, and corporate finance, holds a PhD in biochemistry from Medical Centre University, Geneva, Switzerland.
  • Claim this Profile
Location
Zürich Metropolitan Area, CH
Skills
  • Equity Research
  • Corporate Finance
  • Pharmaceutical Industry
  • Biotechnology
  • Equities
  • Show all
image
image

Refer a Friend to Get
100 Credits For FREE

Refer a Friend Now

Bio

Generated by
Topline AI

Credentials

  • Best Practices de Gouvernance d’Entreprise
    Swiss Board School
    Jun, 2019
    - Apr, 2026

Experience

  • Venture Kick
    • Jury member Biotech
      • Jan 2024 - Present

  • Bioqube Ventures
    • Advisor
      • Oct 2023 - Present

  • Wyss Zurich
    • Zurich, Switzerland
    • Evaluation Board Member
      • Dec 2022 - Present
      • Zurich, Switzerland

  • Bootstrap Europe
    • Scientific Advisor
      • Dec 2020 - Present

  • Amazentis SA
    • Board Member
      • Dec 2017 - Jan 2024

  • Vandria SA
    • Lausanne
    • Board Member
      • Nov 2021 - Nov 2023
      • Lausanne

  • Family Office - Massellaz AG
    • Switzerland
    • Senior Scientific Advisor
      • Mar 2016 - Jul 2023
      • Switzerland

  • Center for Sustainable Finance and Private Wealth Singapore (CSP SG)
    • Zurich, Switzerland
    • Advisory Board Member
      • Jan 2018 - May 2023
      • Zurich, Switzerland

  • Helvea SA, Geneva, Switzerland
    • Senior Pharmaceutical Analyst, Director
      • Sep 2008 - Feb 2016

      Coverage of large European pharmaceuticals – AstraZeneca, GlaxoSmithKline, Bayer, Merck KGAa, Sanofi-aventis, Sanofi-aventis, Novartis, Roche, Stada and Acino.Client meetings and marketing trips, road shows with companies, financial analysis, attending scientific meetings, writing thematic reports

  • Vontobel
    • Pharmaceutical Sell-Side Analyst
      • Oct 2006 - Aug 2008

      Primary responsibilities: coverage of large European pharmaceuticals – Novartis, Roche, AstraZeneca (lead analyst), GlaxoSmithKline (lead analyst), Sanofi-aventis and Merck KGAa – as well as smaller generic and biotech companies such as Acino (previously named Schweizerhall) (lead analyst) and Newron (lead analyst);Secondary responsibilities: client meetings and marketing trips, road shows with companies, financial analysis for corporate finance deals, attending scientific meetings, writing thematic reports

  • Lombard Odier Investment Managers
    • Geneva Area, Switzerland
    • Pharmaceutical analyst
      • Feb 2004 - Oct 2006
      • Geneva Area, Switzerland

Education

  • 1998 - 2003
    PhD in Biochemistry, Medical Centre University, Geneva, Switzerland
    PhD, biochemistry
  • 1997 - 1998
    Scripps Research
    Diploma Work, Oncology
  • 1994 - 1998
    Université de Fribourg - Universität Freiburg
    Diploma, biochemistry

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Venture Capital and Private Equity Principals”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles